Japanese drug maker Otsuka Pharmaceutical has granted US pharmaceutical firm Mylan’s subsidiary an exclusive licen...
Undoubtedly, India is the epicentre for vaccine manufacturing in the world. With many top vaccine giants supplying basic...
At least 600 people have died and over 12,500 people have been affected by the deadly swine flu outbreak in India as of ...
Singapore: Affecting well over 12,000 people so far, Swine flu is sweeping across the Indian subcontinent. The viru...
Singapore: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life scienc...
Singapore: Japan’s Takeda pharmaceuticals have inked two licensing pacts with Biological E for development and del...
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the ap...
Singapore - LifeCell International (India's first and the largest stem cell bank)has made an entry into global platform ...
Cancer is a complex disorder, largely defined as abnormal growth of cells. In contrast to normal cells that divide limit...
In a bid to boost the Indian start up scene, the government is all set to fulfill its promise of setting up of seven new...
This is the first time in Asia that Deep Brain Stimulation (DBS) implantation was performed with a medical robot called ...
Drug firm Zydus Cadila has received approval from the US health regulator to market antihistamine Cyproheptadine Hydroch...
Private equity firm Toro Finserve is raising a USD 500 million fund to invest in real estate for healthcare enterprises....
Prashant Ranganathan, Indian boy has won the world's largest pre-college science competition in the US in the environmen...
Singapore: Indian drug giant Torrent Pharma has acquired a portfolio of generic drugs from Swiss pharma company Novartis...
International Finance Corp (IFC), the private-sector investment arm of the World Bank, will sell its entire 7.5% stake i...
Bangalore based Milann, country’s leading fertility center, becomes the first hospital in India to receive permiss...
Ahmedabad-based pharmaceutical company Claris Lifesciences Ltd has agreed to sell its entire 20% stake in a joint ventur...